Zymeworks Inc (ZYME)
13.68
-0.87
(-5.98%)
USD |
NASDAQ |
Nov 21, 16:00
13.60
-0.08
(-0.58%)
After-Hours: 20:00
Zymeworks Enterprise Value: 645.04M for Nov. 21, 2024
Enterprise Value Chart
Historical Enterprise Value Data
| Date | Value |
|---|---|
| November 21, 2024 | 645.04M |
| November 20, 2024 | 704.97M |
| November 19, 2024 | 720.12M |
| November 18, 2024 | 729.76M |
| November 15, 2024 | 762.82M |
| November 14, 2024 | 822.75M |
| November 13, 2024 | 888.18M |
| November 12, 2024 | 901.27M |
| November 11, 2024 | 896.45M |
| November 08, 2024 | 848.23M |
| November 07, 2024 | 857.88M |
| November 06, 2024 | 777.98M |
| November 05, 2024 | 712.54M |
| November 04, 2024 | 719.43M |
| November 01, 2024 | 617.49M |
| October 31, 2024 | 646.42M |
| October 30, 2024 | 658.13M |
| October 29, 2024 | 650.33M |
| October 28, 2024 | 618.52M |
| October 25, 2024 | 597.08M |
| October 24, 2024 | 596.39M |
| October 23, 2024 | 609.53M |
| October 22, 2024 | 611.60M |
| October 21, 2024 | 613.68M |
| October 18, 2024 | 635.12M |
| Date | Value |
|---|---|
| October 17, 2024 | 634.43M |
| October 16, 2024 | 636.50M |
| October 15, 2024 | 665.90M |
| October 14, 2024 | 628.28M |
| October 11, 2024 | 621.32M |
| October 10, 2024 | 596.27M |
| October 09, 2024 | 588.62M |
| October 08, 2024 | 574.70M |
| October 07, 2024 | 571.92M |
| October 04, 2024 | 577.48M |
| October 03, 2024 | 551.04M |
| October 02, 2024 | 564.96M |
| October 01, 2024 | 562.17M |
| September 30, 2024 | 576.09M |
| September 27, 2024 | 552.26M |
| September 26, 2024 | 555.82M |
| September 25, 2024 | 558.66M |
| September 24, 2024 | 557.95M |
| September 23, 2024 | 576.42M |
| September 20, 2024 | 599.86M |
| September 19, 2024 | 597.02M |
| September 18, 2024 | 559.37M |
| September 17, 2024 | 543.74M |
| September 16, 2024 | 558.66M |
| September 13, 2024 | 560.79M |
Enterprise Value Definition
EV is considered the theoretical purchase ("takeover") price of a business because a purchaser would take on the company's debt, while pocketing the company's cash and gaining a right to all of the company's future earnings.
Enterprise Value Range, Past 5 Years
-22.08M
Minimum
Apr 26 2022
2.189B
Maximum
Jan 08 2021
663.40M
Average
420.09M
Median
Feb 07 2024
Enterprise Value Benchmarks
| NovaBay Pharmaceuticals Inc | 2.798M |
| Palatin Technologies Inc | 15.96M |
| iBio Inc | 12.31M |
| Theriva Biologics Inc | -12.68M |
| Oragenics Inc | 2.273M |
Enterprise Value Related Metrics
| Net Income (Quarterly) | -29.85M |
| Revenue (Quarterly) | 16.00M |
| Total Expenses (Quarterly) | 50.25M |
| EPS Diluted (Quarterly) | -0.39 |
| Profit Margin (Quarterly) | -186.6% |
| Earnings Yield | -10.89% |
| Normalized Earnings Yield | -9.556 |